Literature DB >> 26029576

Bullous emphysema as first presentation of Ehlers-Danlos syndrome in monozygotic twins.

Paolo Ruggeri1, Salvatore Calcaterra1, Giuseppe Girbino1.   

Abstract

Ehlers-Danlos syndrome, characterized by hyperextensible skin, hypermobile joints, and fragile vessels, is the most common heritable disorder of connective tissue and has an estimated prevalence of 1 in 5000. Pulmonary involvement with signs of lung destruction (bullous emphysema) as first presentation is unusual. We report a case of monozygotic twins 37 years old men with occasional evidence of bullous emphysema with previously undiagnosed Ehlers-Danlos syndrome type IV. We emphasize the importance of considering uncommon genetic causes of emphysema in young adults, discuss underlining pathophysiological mechanisms and propose a conservative management and follow-up.

Entities:  

Keywords:  Bullous emphysema; Ehlers-Danlos syndrome; Hemoptysis; Monozygotic twins

Year:  2014        PMID: 26029576      PMCID: PMC4356030          DOI: 10.1016/j.rmcr.2014.12.002

Source DB:  PubMed          Journal:  Respir Med Case Rep        ISSN: 2213-0071


Introduction

Ehlers-Danlos syndrome (EDS) type IV, also known as the vascular type of EDS, is an inherited disorder of connective tissue characterized by arterial and digestive complications which are rarely observed in other forms of EDS and affect 80% of patients by the age of 40 [1]. Pulmonary complications are rare including pneumothorax, hemoptysis, cavitary lung lesions and bullous emphysema [2]. Pulmonary signs is very uncommon as first presentation of type IV EDS [3]. We report a case of twins 37 years old men with occasional evidence of bullous emphysema with previously undiagnosed type IV EDS.

Case presentation

A 37 year man presented to the emergency department for a first episode of hemoptysis accompanied by stabbing right hemithoracic pain. He was a current heavy smoker (29 pack years) and he was working in a fiberglass boats factory. Medical history was negative for preceding pulmonary diseases and positive for capillary fragility with bruising and propensity to develop ecchymosis. Chest x-ray revealed a large distended cystic bullae in the upper right lobe with compression of remaining pulmonary parenchyma. Chest CT show multiple emphysematous bullae in the middle and upper lobe of right lung. In the upper and lingular lobe of left lung paraseptal and panlobular emphysema was also evident (Fig. 1). Patient was transferred to Pulmonary Unit in a stable clinical condition. Arterial gas-analysis was normal during spontaneous breathing and serum blood analysis revealed only mild elevation of CRP, VES and fibrinogen. No abnormality was present in the hemostasis screening test. Bronchoscopy showed blood coming from upper right lobe. Pulmonary function test demonstrated normal lung volumes with moderate reduction of carbon monoxide diffusing capacity (3, 25 ml/min/mmHg/L, 54% pred.) (Table 1). A significant difference between slow and forced vital capacity (6.24 L vs 4.84 L) was evident. Deeping into patient familiar medical history we discovered that patient had a twin homozygous brother current asymptomatic heavy smoker with bullous emphysema occasionally diagnosed by screening chest x-ray. Alpha-1 antitrypsin was in the normal range in both brothers. Skin was found to be thin and translucent with slightly hyperextensive of small joints of extremities (Fig. 2). An EDS was so suspected. Characteristic facial appearance was not so evident. Molecular gene testing was done to confirm the diagnosis in twins. Genomic DNA was extracted from peripheral blood leukocytes. Sequencing analysis of the patient's DNA revealed a novel missense mutation (c.2996G[A]; Gly999Asp) in exon 41 of the COL3A1 gene characteristic of EDS type IV. Echocardiography revealed no significant alterations in twins. Natural course of disease in the hospitalized twin was benign and hemoptysis with thoracic pain disappeared after two days after hospital admission. Twins were advised to stop smoking and has been followed for pulmonary and vascular emergencies. After three months twins are in a stable clinical condition.
Fig. 1

Chest computed tomography showing multiple emphysematous bullae in the middle and upper lobe of right lung. In the upper and lingular lobe of left lung paraseptal and panlobular emphysema was also evident.

Table 1

Pulmonary function test.

ReferenceActual% Reference
Spirometry
FVC (L)4.484.84108
FEV1 (L)3.734.14111
FEV1/FVC (%)8680107
FEV1/SVC (%)668380
FEF 25–75% (L/sec)4.394.48102
Lung Volumes
SVC (L)4.486.24139
IC(L)3.274.17127
ERV(L)1.212.08171
TGV (L)3.233.85119
RV (Pleth) (L)1.821.7797
TLC (Pleth) (L)6.508.02123
RV/TLC (Pleth) %292276
Diffusing Capacity
DLCOcor (ml/min/mmHg)3122.8474
DL/VA (ml/min/mmHg/L)6.023.2554
Fig. 2

Slightly hyperextensive of small joints of extremities.

Discussion

The EDS is an inherited defect (autosomal dominant) of connective tissue characterized by soft and hyperextensible thin skin, hypermobile joints, and a particular tendency to bruising and bleeding. Eight or more clinical types are currently recognized [4]. Specific biochemical abnormalities of collagen are known in EDS [4]. Literature review reveal no systematic association between EDS and pulmonary emphysema with only few cases report [5,6]. A more intrinsic correlation was found between Cutis Laxa and pulmonary emphysema [7]. In our case a differential diagnosis for congenital emphysematous diseases can be made (Table 2). EDS was more probable because of twin association. Obviously emphysema in both twins was aggravated by cigarette smoke exposure. Upper lobes predominance is attributable to the pressure gradient that augments stress to the upper lung zones. Moreover, the right-sided preponderance, as seen in this case, may be attributed to the larger septal surface area, reduced connective tissue support, and poorer blood supply of the lung. The ball-valve mechanism may accentuate dynamic hyperinflation in the emphysematous lung. Marked difference between SVC and FVC demonstrated collapsible airways due to decreased lung compliance during forced maneuver [8]. In our case FRC was measured by pletismography. It would have been interesting to perform a comparison with the determination of the FRC measured by He dilution test that only evaluates the ventilated volume. Significant reduction al DLCO/VA is attributable to significant reduction of lung surface and lung blood supply. In both twins surgical reduction of emphysema was not recommended for several reasons: traditionally, bullectomy is offered to patients in whom bulla fill half of the chest cavity with relatively preserved adjacent parenchyma [5]. In the case presented a diffuse bullous, paraseptal and panlobular emphysema was evident. Postoperative hemorrhagic complication of surgery in EDS patients is very high [5] and this procedure should be reserved to only emergency situations like massive pneumothorax or non resolving hemoptysis [9]. Bronchoscopic lung volume reduction with endobronchial valve is not indicated because patient wasn't hyperinflated and coil or thermal vapor ablation treatment has not been recommended for the risk of severe complications.
Table 2

Genetic diseases associated with bullous emphysema.

Inherited defect of connective: Cutis laxa, Ehlers-Danlos syndrome, Marfan syndrome
Idiopathic giant bullous emphysema (Vanishing lung syndrome)
Birt-Hogg-Dubè Syndrome
Neurofibromatosis
Placental transmogrification of the lung
Fabry disease
Salla disease
Early resolving symptoms let us to consider a conservative approach with close monitoring and immediate smoking cessation program. The absence of chronic respiratory symptoms, such as exertional dyspnea, in presence of normal pulmonary function test not suggested inhaled treatment with bronchodilator agents. A vascular follow-up is moreover important for known cardiovascular complications. A genetic counseling was extended to other family members.

Conclusion

Rare genetic causes can be considered in young adults presenting with not previous diagnosed bullous emphysema. EDS type IV can presented with predominantly pulmonary manifestation that can be early diagnosed and managed very carefully to avoid more serious complications.

Consent

Written informed consent was obtained from the twins patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.

Author's contribution

P.R. have made substantial contributions to conception, design and drafting of case report manuscript. S.C. have made been involved in data acquisition. G.G. have been involved to revisiting manuscript critically.
  9 in total

1.  Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.

Authors:  M Pepin; U Schwarze; A Superti-Furga; P H Byers
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

2.  The detection of collapsible airways contributing to airflow limitation.

Authors:  E D Chan; C G Irvin
Journal:  Chest       Date:  1995-03       Impact factor: 9.410

3.  Emergent bullectomy for acute respiratory failure in Ehlers-Danlos syndrome.

Authors:  Zeenat Safdar; Mary O'Sullivan; Janet M Shapiro
Journal:  J Intensive Care Med       Date:  2004 Nov-Dec       Impact factor: 3.510

4.  A case of congenital cutis laxa (generalized elastolysis).

Authors:  Paul Champion; Frank Ryan
Journal:  Can Respir J       Date:  2005-04       Impact factor: 2.409

Review 5.  The Ehlers-Danlos syndrome, a disorder with many faces.

Authors:  A De Paepe; F Malfait
Journal:  Clin Genet       Date:  2012-03-15       Impact factor: 4.438

6.  Chronic pulmonary disease in a child with the Ehlers-Danlos syndrome.

Authors:  M J Cavanaugh; D M Cooper
Journal:  Acta Paediatr Scand       Date:  1976-11

7.  Abnormalities of the lungs and thoracic cage in the Ehlers-Danlos syndrome.

Authors:  J G Ayres; F M Pope; J F Reidy; T J Clark
Journal:  Thorax       Date:  1985-04       Impact factor: 9.139

Review 8.  Treatment of vascular Ehlers-Danlos syndrome: a systematic review.

Authors:  David Bergqvist; Martin Björck; Anders Wanhainen
Journal:  Ann Surg       Date:  2013-08       Impact factor: 12.969

9.  Respiratory complications of Ehlers-Danlos syndrome type IV.

Authors:  Katsuhiko Hatake; Yoshifumi Morimura; Risa Kudo; Wataru Kawashima; Shogo Kasuda; Hiroki Kuniyasu
Journal:  Leg Med (Tokyo)       Date:  2012-08-30       Impact factor: 1.376

  9 in total
  4 in total

1.  Pulmonary and diaphragmatic pathology in collagen type I α1 mutant mice with osteogenesis imperfecta.

Authors:  Carolyn J Baglole; Feng Liang; Hussein Traboulsi; Angela Rico de Souza; Christian Giordano; Josephine T Tauer; Frank Rauch; Basil J Petrof
Journal:  Pediatr Res       Date:  2018-05-09       Impact factor: 3.756

2.  Haploinsufficiency of Col5a1 causes intrinsic lung and respiratory changes in a mouse model of classical Ehlers-Danlos syndrome.

Authors:  Jordan Fett; Milena Dimori; John L Carroll; Roy Morello
Journal:  Physiol Rep       Date:  2022-04

Review 3.  An evidence-based review of primary spontaneous pneumothorax in the adolescent population.

Authors:  Paria M Wilson; Beth Rymeski; Xuefeng Xu; William Hardie
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-06-18

Review 4.  A review of respiratory manifestations and their management in Ehlers-Danlos syndromes and hypermobility spectrum disorders.

Authors:  Karan Chohan; Nimish Mittal; Laura McGillis; Laura Lopez-Hernandez; Encarna Camacho; Maxim Rachinsky; Daniel Santa Mina; W Darlene Reid; Clodagh Mai Ryan; Kateri Agnes Champagne; Ani Orchanian-Cheff; Hance Clarke; Dmitry Rozenberg
Journal:  Chron Respir Dis       Date:  2021 Jan-Dec       Impact factor: 2.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.